Zobrazeno 1 - 10
of 61
pro vyhledávání: '"V R, Chechetkin"'
Autor:
Vasily V. Lobzin, V. R. Chechetkin
A world-wide COVID-19 pandemic intensified strongly the studies of molecular mechanisms related to the coronaviruses. The origin of coronaviruses and the risks of human-to-human, animal-to-human, and human-to-animal transmission of coronaviral infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce99a140e05783b347d6b0326687739
Autor:
Vasily V. Lobzin, V. R. Chechetkin
Publikováno v:
Journal of Biomolecular Structure & Dynamics
article-version (VoR) Version of Record
Journal of Biomolecular Structure and Dynamics
article-version (VoR) Version of Record
Journal of Biomolecular Structure and Dynamics
The genomic ssRNA of coronaviruses is packaged within a helical nucleocapsid. Due to transitional symmetry of a helix, weakly specific cooperative interaction between ssRNA and nucleocapsid proteins leads to the natural selection of specific quasi-pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8bc1fd9f0752f1e4b3d1c4875e4a6e
http://arxiv.org/abs/2007.10274
http://arxiv.org/abs/2007.10274
Autor:
V. R. Chechetkin, V. V. Lobzin
In many processes, the variations in underlying characteristics can be approximated by noisy multi-periodic patterns. If large-scale patterns are superimposed by a noise with long-range correlations, the detection of multi-periodic patterns becomes e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8f93330f3651c9113458644b5c9b82
http://arxiv.org/abs/1912.02230
http://arxiv.org/abs/1912.02230
Autor:
O. V. Kretova, M. A. Gorbacheva, D. M. Fedoseeva, Y. V. Kravatsky, V. R. Chechetkin, N. A. Tchurikov
Publikováno v:
Molecular Biology. 52:510-513
Autor:
Maria A. Gorbacheva, Nickolai A. Tchurikov, Y. V. Kravatsky, V. R. Chechetkin, Olga V. Kretova, D. M. Fedoseeva
Publikováno v:
Molecular Biology. 52:393-397
HIV-1 is one of the most variable viruses. The development of gene therapy technology using RNAi for AIDS/HIV-1 treatment is a potential alternative for traditional anti-retroviral therapy. Anti-HIV-1 siRNA should aim to exploit the most conserved vi
Autor:
D. M. Fedoseeva, Olga V. Kretova, Maria A. Gorbacheva, Y V Kravatskya, V. R. Chechetkin, Nickolai A. Tchurikov
Publikováno v:
Молекулярная биология. 52:591-594
Gene therapy for AIDS based on RNA interference (RNAi) is currently looked upon as a promising alternative to conventional antiretroviral chemotherapy. The high variability of HIV-1 is the main challenge in developing new approaches to AIDS therapy.
Autor:
D. M. Fedoseeva, Nataliya V. Melnikova, Maria A. Gorbacheva, Yuri V. Kravatsky, V. R. Chechetkin, Maria P. Gashnikova, Olga V. Kretova, Natalya M. Gashnikova, Nickolai A. Tchurikov
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss, Pp 330-344 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
RNAi has been suggested for use in gene therapy of HIV/AIDS, but the main problem is that HIV-1 is highly variable and could escape attack from the small interfering RNAs (siRNAs) due to even single nucleotide substitutions in the potential targets.
Autor:
D. M. Fedoseeva, Nickolai A. Tchurikov, Yuri V. Kravatsky, V. R. Chechetkin, Olga V. Kretova, Ivan Y Slovohotov, E. S. Klushevskaya
Publikováno v:
Cells
Volume 8
Issue 11
Cells, Vol 8, Iss 11, p 1393 (2019)
Volume 8
Issue 11
Cells, Vol 8, Iss 11, p 1393 (2019)
Human rDNA clusters form numerous contacts with different chromosomal regions as evidenced by chromosome conformation capture data. Heterochromatization of rDNA genes leads to heterochromatization in different chromosomal regions coupled with the act
Autor:
Nickolai A. Tchurikov, V. R. Chechetkin, Maria A. Gorbacheva, Olga V. Kretova, D. M. Fedoseeva, Natalya M. Gashnikova, Yuri V. Kravatsky, Dmitri V. Sosin, Ildar R. Alembekov
Publikováno v:
Gene. 583:78-83
Highly active antiretroviral therapy has greatly reduced the morbidity and mortality of AIDS. However, many of the antiretroviral drugs are toxic with long-term use, and all currently used anti-HIV agents generate drug-resistant mutants. Therefore, t
Autor:
Y. V. Kravatsky, V. R. Chechetkin, D. M. Fedoseeva, M. A. Gorbacheva, O. V. Kretova, N. A. Tchurikov
Publikováno v:
Molecular Biology. 50:417-421